Structural landscape of activation, desensitization and inhibition in the human TRPM4 channel
TRPM4 is a member of the transient receptor potential melastatin channel subfamily and functions as a Ca<sup>2+</sup>-activated monovalent-selective cation channel. It is widely expressed in various cells and tissues, where its activation depolarizes the plasma membrane potential and modulates various Ca<sup>2+</sup>-dependent biological processes. TRPM4 activity is potentiated by membrane phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P<sub>2</sub>) and inhibited by cytosolic free adenosine triphosphate (ATP), allowing the channel to transition between different functional states in response to dynamic changes in cellular Ca<sup>2+</sup>, ATP and PtdIns(4,5)P<sub>2</sub> levels during signaling events. Here we present single-particle cryo-electron microscopy structures of human TRPM4 in four distinct states: apo closed, Ca<sup>2+</sup>-bound putative desensitized, Ca<sup>2+</sup>-PtdIns(4,5)P<sub>2</sub>-bound open and ATP-bound inhibited. Combined with mutagenesis and electrophysiological analyses, these structures reveal the molecular mechanisms underlying TRPM4 activation, desensitization and inhibition. Given the central roles of Ca<sup>2+</sup>, PtdIns(4,5)P<sub>2</sub> and ATP in cellular signaling, this work provides a structural foundation to decipher the physiological functions of TRPM4 across diverse biological systems.
Authors
- Weizhong Zeng (ORCID: https://orcid.org/0000-0002-9636-2086)
- Celso M. Teixeira‐Duarte (ORCID: https://orcid.org/0000-0002-8036-7069)
- Youxing Jiang (ORCID: https://orcid.org/0000-0002-1874-0504)
Institutions
- Howard Hughes Medical Institute (US)
- Southwestern Medical Center (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Nature Structural & Molecular Biology
- Published
- 2025-10-31
- DOI
- https://doi.org/10.1038/s41594-025-01705-3
- Citations
- 2
- Primary Topic
- Ion Channels and Receptors
- Type
- article
- Field-Weighted Citation Impact
- 2.93
Funders
- Cancer Prevention and Research Institute of Texas
- University of Texas Southwestern Medical Center